Taysha Gene Therapies (TSHA)
(Delayed Data from NSDQ)
$2.03 USD
-0.12 (-5.58%)
Updated Sep 23, 2024 04:00 PM ET
After-Market: $2.04 +0.01 (0.49%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth A Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/12/2024
Time: -- |
9/2024 | $-0.08 | 0.00% |
Earnings Summary
For their last quarter, Taysha Gene Therapies (TSHA) reported earnings of -$0.09 per share, beating the Zacks Consensus Estimate of $-0.10 per share. This reflects a positive earnings surprise of 10.00%. Look out for TSHA's next earnings release expected on November 12, 2024. For the next earning release, we expect the company to report earnings of -$0.08 per share, reflecting a year-over-year increase of 38.46%.
Earnings History
Price & Consensus
Zacks News for TSHA
Taysha Gene Therapies, Inc. (TSHA) Reports Q2 Loss, Lags Revenue Estimates
TSHA: What are Zacks experts saying now?
Zacks Private Portfolio Services